Clinical trials in late-life depression: Revisited

American Journal of Geriatric Psychiatry

Volumn 10, Issue 5, 2002, Pages 503-505

  Roose, Steven P ^a   Sackeim, Harold A ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

DEPRESSION; EDITORIAL; HAMILTON SCALE; PATHOPHYSIOLOGY; REMISSION; SOCIAL PSYCHOLOGY; VALIDATION PROCESS;

EID: 0036732009     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200209000-00002     Document Type: Editorial

References (11)

1. Placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression
2. Antidepressant early response and remission with venlafaxine vs. fluoxetine in depressed geriatric outpatients
3. Effectiveness of sertraline in elderly depression: Results of a placebo-controlled trial
4. Treatment of depression in the "old-old:" A randomized, double-blind, placebo-controlled trial of citalopram in patients at least 75 years of age
5. Citalopram versus nortriptyline in late-life depression: A 12-week randomized single-blind study
6. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease
7. A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed patients and outpatients
8. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients
9. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life
10. Double-blind randomized comparison of mirtazapine vs. paroxetine in elderly depressed patients
11. Redefining remission in late-life depression